SS Innovations International (SSII) Change in Account Payables (2022 - 2026)
SS Innovations International (SSII) reported Change in Account Payables of -$704764.0 for Q1 2026, down 153.03% on a YoY basis from $1.3 million in Q1 2025, and down 232.17% sequentially from $533226.0 in Q4 2025.
SS Innovations International (SSII) Change in Account Payables (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Change in Account Payables data on file, last reported at -$704764.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 153.03% year-over-year to -$704764.0; the trailing twelve-month figure through Mar 2026 stood at $844018.0 (down 53.47% YoY), and the FY2025 full-year result was $2.9 million, up 103.98% from the prior year.
- Change in Account Payables eased to -$704764.0 in Q1 2026, from $533226.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.5 million in Q2 2025 to a low of -$1.4 million in Q3 2025.
- A 5-year average of $297829.7 and a median of $183201.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 11752.61% in 2024 and slumped 313.89% in 2025, its largest moves.
- Tracing SSII's Change in Account Payables over 5 years: stood at $183201.0 in 2022, then declined by 0.93% to $181498.0 in 2023, then soared by 183.07% to $513770.0 in 2024, then grew by 3.79% to $533226.0 in 2025, then tumbled by 232.17% to -$704764.0 in 2026.
- Business Quant data shows SSII's Change in Account Payables at -$704764.0 in Q1 2026, $533226.0 in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | - |
| 10 | SS Innovations International | 784.03 Mn | 760.42 Mn | 5.33 Mn | -704,764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -704,764.00 |
| Mar 31, 2026 | -704,764.00 |
| Dec 31, 2025 | 533,226.00 |
| Dec 31, 2025 | 533,226.00 |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 513,770.00 |
| Dec 31, 2024 | 513,770.00 |
| Sep 30, 2024 | 672,239.00 |
| Sep 30, 2024 | 672,239.00 |
| Jun 30, 2024 | -701,262.00 |
| Jun 30, 2024 | -701,262.00 |
| Mar 31, 2024 | 926,083.00 |
| Mar 31, 2024 | 926,083.00 |
| Dec 31, 2023 | 181,498.00 |
| Dec 31, 2023 | 181,498.00 |